Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Dermatology

Date Submitted: Mar 10, 2023
Open Peer Review Period: Mar 10, 2023 - May 5, 2023
Date Accepted: Jun 14, 2023
Date Submitted to PubMed: Aug 26, 2023
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Where Are We With Teledermatology? Two Years in the Wake of COVID-19

Sim W, Choi ECE, Chandran NS

Where Are We With Teledermatology? Two Years in the Wake of COVID-19

JMIR Dermatol 2023;6:e47168

DOI: 10.2196/47168

PMID: 21127633

PMCID: 10335151

Where are we with Teledermatology? Two years in the wake of COVID-19

  • Wilson Sim; 
  • Ellie Ci-En Choi; 
  • Nisha Suyien Chandran

ABSTRACT

Much attention was brought to teledermatology during the COVID-19 pandemic, but how has this trend held up? Two years on, we review the trends of teledermatology in our institute and globally, and discuss the role of teledermatology moving forward. Data from our institution indicated a lower uptake of teledermatology compared to global trends. The number of teleconsults planned increased with coordinated institutional efforts to bolster the use of teledermatology in response to the COVID-19 situation, however, the number of teleconsults conducted remained largely stable between 1%-2% of total consultations. Reasons for declining teledermatology included a perceived lower quality of care, having to pay the same price as a physical consultation and technological barriers. While the increase in accessibility to dermatological care and cost savings of teledermatology may be less pronounced in highly-connected city-states like Singapore, teledermatology plays a salient role in improving service options, flexibility of pivoting to virtual care in times of need, and offering an effective and feasible model of care in various settings.


 Citation

Please cite as:

Sim W, Choi ECE, Chandran NS

Where Are We With Teledermatology? Two Years in the Wake of COVID-19

JMIR Dermatol 2023;6:e47168

DOI: 10.2196/47168

PMID: 21127633

PMCID: 10335151

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.